Yıl: 2023 Cilt: 48 Sayı: 3 Sayfa Aralığı: 395 - 410 Metin Dili: İngilizce İndeks Tarihi: 01-12-2023

Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates

Öz:
Some new triazole containing acetamide derivatives 9-20 using paracetamol as starting material were synthesized and their structure were characterized by FTIR, 1H-NMR, 13C-NMR and MS data. In vitro cytotoxic activities of all synthesized molecules against five cancer cell lines (human lung cancer A549, human chronic myelogenous leukemia K562, human breast cancer MCF-7, human prostate cancer PC-3, human neuroblastoma SH-SY5Y cell lines) were examined and were also tested their cytotoxic effect on mouse embryonic fibroblast cells (NIH/3T3) to define selectivity. MTT assay were used these in vitro activity studies. Additionally, twelve target compounds 9-20 were screened for their mPGES-1 and COX-1/2 inhibitory activities. While none of the synthesized compounds showed a significant inhibition against both cancer cells and mPGES-1 as well as COX-1/2, it was determined that they were not cytotoxic against healthy cells, too. Finally, ADMET data were presented by predicting the drug-like properties of newly synthesized compounds using computational methods.
Anahtar Kelime: Paracetamol 1 2 4-triazole cancer mPGES-1 COX- 1/2

Yeni Parasetamol-Triazol Konjugatlarının Sentezi ve Biyolojik Değerlendirmesi

Öz:
Başlangıç maddesi olarak parasetamol kullanılarak bazı yeni triazol içeren asetamid türevleri 9-20 sentezlendi ve yapıları FTIR, NMR (1H and 13C) ve kütle spektral verileri ile karakterize edildi. Beş insan kanser hücre hattına (akciğer kanseri A549, kronik miyelojenöz lösemi K562, meme kanseri MCF-7, prostat kanseri PC-3, nöroblastoma SH-SY5Y hücre hatları) karşı sentezlenen tüm moleküllerin in vitro sitotoksik aktiviteleri incelendi ve ayrıca seçiciliği tanımlamak için fare embriyonik fibroblast hücreleri (NIH/3T3) üzerinde sitotoksik etkileri MTT yöntemiyle test edildi. Ek olarak, on iki hedef bileşik 9-20, mPGES-1 ve COX-1/2 inhibe edici etkileri açısından tarandı. Sentezlenen bileşiklerin hiçbiri hem kanser hücrelerine hem de mPGES-1 ve COX-1/2 enzimlerine karşı anlamlı bir inhibisyon göstermezken, sağlıklı hücrelere karşı da sitotoksik olmadıkları belirlendi. Son olarak yeni sentezlenen bileşiklerin ADMET özellikleri in siliko yöntemler kullanılarak tahmin edildi.
Anahtar Kelime: Parasetamol 1 2 4-triazol kanser mPGES-1 COX-1/2

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Akasaka,H.,So,S.P.,&Ruan,K.H.(2015).Relationship of the Topological Distances and Activities between mPGES-1 and COX-2 versus COX-1: Implications of the Different Post-Translational Endoplasmic Reticulum Organizations of COX- 1 and COX-2. Biochemistry, 54(23), 3707–3715. https://doi.org/10.1021/acs.biochem.5b00339
  • Bülbül, B., Ding, K., Zhan, C. G., Çiftçi, G., Yelekçi, K., Gürboğa, M., ... Küçükgüzel, İ. (2022). Novel 1,2,4-triazoles derived from Ibuprofen: synthesis and in vitro evaluation of their mPGES-1 inhibitory and antiproliferative activity. Molecular Diversity, (Early Access). https://doi.org/10.1007/ s11030-022-10551-0
  • Chang, H. H., Song, Z., Wisner, L., Tripp, T., Gokhale, V., & Meuillet, E. J. (2012). Identification of a novel class of anti-inflammatory compounds with anti-tumor activity in colorectal and lung cancers. Investigational New Drugs, 30, 1865–1877.
  • Crofford, L. J. (1997). COX-1 and COX-2 tissue expression: implications and predictions. The Journal of Rheumatology. Supplement, 49, 15—19. Retrieved from http://europepmc.org/abstract/ MED/9249646
  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 1–13. https://doi.org/10.1038/ srep42717
  • Demirbolat, İ., Kulabaş, N., Gürboğa, M., Bingöl- Özakpınar, Ö., Çiftçi, G., Yelekçi, K., ... Küçükgüzel, İ. (2022). Synthesis and evaluation of antiproliferative and mPGES-1 inhibitory activities of novel carvacrol-triazole conjugates. Organic Communications, 15(4), 356–377.
  • Demirci, A., Karayel, K. G., Tatar, E., Okullu, S. Ö., Unübol, N., Taşli, P. N., ... Küçükgüzel, I. (2018). Synthesis and evaluation of novel 1,3,4-thiadiazole–fluoroquinolone hybrids as antibacterial, antituberculosis, and anticancer agents. Turkish Journal of Chemistry, 42(3), 839– 858. https://doi.org/10.3906/kim-1710-35
  • Erensoy, G., Ding, K., Zhan, C. G., Çiftçi, G., Yelekçi, K., Duracık, M., ... Küçükgüzel, İ. (2023). Synthesis, in vitro and in silico studies on novel 3-aryloxymethyl-5-[(2-oxo-2-arylethyl)sulfanyl]- 1,2,4-triazoles and their oxime derivatives as potent inhibitors of mPGES-1. Journal of Molecular Structure, 1272, 134154. https://doi. org/10.1016/j.molstruc.2022.134154
  • Graham, G. G., Davies, M. J., Day, R. O., Mohamudally, A., & Scott, K. F. (2013). The modern pharmacology of paracetamol : therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. 201–232. https://doi. org/10.1007/s10787-013-0172-x
  • Haider, B., & Hamada, M. I. (2012). 4-Thiazolidinones in Heterocyclic Synthesis: Synthesis of Novel Enaminones, Azolopyrimidines and 2-Arylimino-5-arylidene-4-thiazolidinones. Molecules, 17, 6362–6385. https://doi.org/10.3390/ molecules17066362
  • Hanaka, H., Pawelzik, S. C., Johnsen, J. I., Rakonjac, M., Terawaki, K., Rasmuson, A., ... Rådmark, O. (2009). Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells. Proceedings of the National Academy of Sciences, 106, 18757–18762.
  • He, S., Li, C., Liu, Y., & Lai, L. (2013). Discovery of highly potent microsomal prostaglandin E2 synthase 1 inhibitors using the active conformation structural model and virtual screen. Journal of Medicinal Chemistry, 56(8), 3296–3309. https:// doi.org/10.1021/jm301900x
  • Howe, L. R., Subbaramaiah, K., Kent, C. V., Zhou, X. K., Chang, S. H., Hla, T., ... Dannenberg, A. J. (2013). Genetic deletion of microsomal prostaglandine synthase-1 suppresses mouse mammary tumor growth and angiogenesis. Prostaglandins & Other Lipid Mediators, 106, 99–105.
  • Kock, A., Larsson, K., Bergqvist, F., Eissler, N., Elfman, L. H. M., Raouf, J., ... Kogner, P. (2018). Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth. EBioMedicine, 32, 84–92.
  • Küçükgüzel, İ, Küçükgüzel, S. G., Rollas, S., & Kiraz, M. (2001). Some 3-thioxo/alkylthio-1,2,4- triazoles with a substituted thiourea moiety as possible antimycobacterials. Bioorganic & Medicinal Chemistry Letters, 11(13), 1703–1707. Retrieved from http://www.ncbi.nlm.nih.gov/ pubmed/11425542
  • Küçükgüzel, İlkay, Tatar, E., Küçükgüzel, Ş. G., Rollas, S., & De Clercq, E. (2008). Synthesis of some novel thiourea derivatives obtained from 5-[(4-aminophenoxy)methyl]-4-alkyl/ aryl-2,4-dihydro-3H-1,2,4-triazole-3-thiones and evaluation as antiviral/anti-HIV and anti-tuberculosis agents. European Journal of Medicinal Chemistry, 43(2), 381–392. https://doi. org/10.1016/j.ejmech.2007.04.010
  • Küçükgüzel, Ş. G., Küçükgüzel, I., Tatar, E., Rollas, S., Sahin, F., Güllüce, M., ... Kabasakal, L. (2007). Synthesis of some novel heterocyclic compounds derived from diflunisal hydrazide as potential anti- infective and anti-inflammatory agents. European Journal of Medicinal Chemistry, 42(7), 893–901. https://doi.org/10.1016/j.ejmech.2006.12.038
  • Kulabaş, N., Tatar, E., Bingöl Özakpınar, Ö., Özsavcı, D., Pannecouque, C., De Clercq, E., & Küçükgüzel, İ. (2016). Synthesis and antiproliferative evaluation of novel 2-(4H-1,2,4-triazole-3-ylthio)acetamide derivatives as inducers of apoptosis in cancer cells. European Journal of Medicinal Chemistry, 121, 58– 70. https://doi.org/10.1016/j.ejmech.2016.05.017
  • Kulabaş, N., Türe, A., Bozdeveci, A., Krishna, V. S., Alpay Karaoğlu, Ş., Sriram, D., & Küçükgüzel, İ. (2022). Novel fluoroquinolones containing 2-arylamino-2-oxoethyl fragment: Design, synthesis, evaluation of antibacterial and antituberculosis activities and molecular modeling studies. Journal of Heterocyclic Chemistry, 59(5), 909–926. https://doi.org/10.1002/jhet.4430
  • Larsson, K., Steinmetz, J., Bergqvist, F., Arefin, S., Spahiu, L., Wannberg, J., ... Jakobsson, P. J. (2019). Biological characterization of new inhibitors of microsomal PGE synthase-1 in preclinical models of inflammation and vascular tone. British Journal of Pharmacology, 176(24), 4625–4638.
  • Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3–25.
  • Morar, C., Cost, L., Lameiras, P., Antheaume, C., & Darabantu, M. (2015). Convergent Versus Divergent Three-Step Synthesis of the First (4-Aminophenoxy)alkanoic Acid–Based Tripodal Melamines. Synthetic Communications, 45(14), 1688–1695. https://doi.org/10.1080/00397911.20 15.1041048
  • Murakami, M. (2011). Lipid Mediators in Life Science. Experimental Animals, 60(May 2010), 7–20. https://doi.org/10.1538/expanim.60.7
  • Nargund, L. V. G., Reddy, G. R. N., & Hariprasad, V. (1994). Anti-inflammatory Activity of Substituted 1,3,4-Oxadiazoles. Journal of Pharmaceutical Sciences, 83(2), 246–248. https://doi.org/10.1002/ jps.2600830226
  • Sander, T., Freyss, J., Von Korff, M., & Rufener, C. (2015). DataWarrior: An open-source program for chemistry aware data visualization and analysis. Journal of Chemical Information and Modeling, 55(2), 460–473. https://doi.org/10.1021/ci500588j
  • Sasaki, Y., Nakatani, Y., & Hara, S. (2015). Role of microsomal prostaglandin E synthase-1 (mPGES-1)-derived prostaglandin E2 in colon carcinogenesis. Prostaglandins & Other Lipid Mediators, 121, 42–45.
  • Shay, A. E., Diwakar, B. T., Guan, B.-J., Narayan, V., Urban, J. F. J., & Prabhu, K. S. (2017). IL-4 up-regulates cyclooxygenase-1 expression in macrophages. The Journal of Biological Chemistry, 292(35), 14544–14555. https://doi.org/10.1074/ jbc.M117.785014
  • Svetkin, Y. V., Minlibaeva, A. N., & Khafizova, N. A. (1961). Reaction of ketene with nitrogenous bases. IX. Chloroacetylation of primary aromatic amines. Zhurnal Obshchei Khimii, 31, 2023–2023.
  • WHO. (2022). Cancer. Retrieved August 30, 2023, from https://www.who.int/news-room/fact- sheets/detail/cancer
  • Yurttaş, L., Evren, A. E., Kubilay, A., & Temel, H. E. (2021). Synthesis of New 1,2,4-Triazole Derivatives and Investigation of Their Matrix Metalloproteinase-9(MMP-9)InhibitionProperties. 59(2), 0–2. https://doi.org/10.23893/1307-2080. APS.05913
  • Zengin, M., Unsal Tan, O., Arafa, R. K., & Balkan, A. (2022). Design and synthesis of new 2-oxoquinoxalinyl-1,2,4-triazoles as antitumor VEGFR-2 inhibitors. Bioorganic Chemistry, 121, 105696.
  • Zhai, W., Hu, Y., Zhang, Y., Zhang, G., Chen, H., Tan, X., ... Wu, J. (2022). A systematic review of phytochemicals from Chinese herbal medicines for non-coding RNAs-mediated cancer prevention and treatment: From molecular mechanisms to potential clinical applications. Medicine in Novel Technology and Devices, 16(November). https:// doi.org/10.1016/j.medntd.2022.100192
  • Zhao, Y. H., Abraham, M. H., Le, J., Hersey, A., Luscombe, C. N., Beck, G., ... Cooper, I. (2002). Rate-limited steps of human oral absorption and QSAR studies. Pharmaceutical Research, 19(10), 1446–1457. https://doi. org/10.1023/A:1020444330011
  • Zhaowen, L., Li, Z., Chunfen, X., Yong, Y., Fanbo, Z., & Kaixun, H. (2007). Anticancer activities of some arylcarbamoylalkyltriphenylphosphonium chlorides. Medicinal Chemistry Research, 16(7–9), 380–391. https://doi.org/10.1007/s00044-007- 9050-7
APA kulabaş n, GURBOGA M, Bingöl Özakpınar Ö, Liu J, Jakobson P, Danış Ö, Ogan A, Küçükgüzel İ (2023). Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. , 395 - 410.
Chicago kulabaş necla,GURBOGA MERVE,Bingöl Özakpınar Özlem,Liu Jianyang,Jakobson Per-Johan,Danış Özkan,Ogan Ayse,Küçükgüzel İlkay Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. (2023): 395 - 410.
MLA kulabaş necla,GURBOGA MERVE,Bingöl Özakpınar Özlem,Liu Jianyang,Jakobson Per-Johan,Danış Özkan,Ogan Ayse,Küçükgüzel İlkay Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. , 2023, ss.395 - 410.
AMA kulabaş n,GURBOGA M,Bingöl Özakpınar Ö,Liu J,Jakobson P,Danış Ö,Ogan A,Küçükgüzel İ Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. . 2023; 395 - 410.
Vancouver kulabaş n,GURBOGA M,Bingöl Özakpınar Ö,Liu J,Jakobson P,Danış Ö,Ogan A,Küçükgüzel İ Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. . 2023; 395 - 410.
IEEE kulabaş n,GURBOGA M,Bingöl Özakpınar Ö,Liu J,Jakobson P,Danış Ö,Ogan A,Küçükgüzel İ "Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates." , ss.395 - 410, 2023.
ISNAD kulabaş, necla vd. "Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates". (2023), 395-410.
APA kulabaş n, GURBOGA M, Bingöl Özakpınar Ö, Liu J, Jakobson P, Danış Ö, Ogan A, Küçükgüzel İ (2023). Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. FABAD Journal of Pharmaceutical Sciences, 48(3), 395 - 410.
Chicago kulabaş necla,GURBOGA MERVE,Bingöl Özakpınar Özlem,Liu Jianyang,Jakobson Per-Johan,Danış Özkan,Ogan Ayse,Küçükgüzel İlkay Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. FABAD Journal of Pharmaceutical Sciences 48, no.3 (2023): 395 - 410.
MLA kulabaş necla,GURBOGA MERVE,Bingöl Özakpınar Özlem,Liu Jianyang,Jakobson Per-Johan,Danış Özkan,Ogan Ayse,Küçükgüzel İlkay Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. FABAD Journal of Pharmaceutical Sciences, vol.48, no.3, 2023, ss.395 - 410.
AMA kulabaş n,GURBOGA M,Bingöl Özakpınar Ö,Liu J,Jakobson P,Danış Ö,Ogan A,Küçükgüzel İ Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. FABAD Journal of Pharmaceutical Sciences. 2023; 48(3): 395 - 410.
Vancouver kulabaş n,GURBOGA M,Bingöl Özakpınar Ö,Liu J,Jakobson P,Danış Ö,Ogan A,Küçükgüzel İ Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates. FABAD Journal of Pharmaceutical Sciences. 2023; 48(3): 395 - 410.
IEEE kulabaş n,GURBOGA M,Bingöl Özakpınar Ö,Liu J,Jakobson P,Danış Ö,Ogan A,Küçükgüzel İ "Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates." FABAD Journal of Pharmaceutical Sciences, 48, ss.395 - 410, 2023.
ISNAD kulabaş, necla vd. "Synthesis and Biological Evaluation of Novel Paracetamol-Triazole Conjugates". FABAD Journal of Pharmaceutical Sciences 48/3 (2023), 395-410.